申请人:Abbott Laboratories
公开号:US05629325A1
公开(公告)日:1997-05-13
Novel 3-pyridyloxymethyl heterocyclic ether compounds of the formula: ##STR1## or the pharmaceutically-acceptable salts or prodrugs thereof are selective and potent ligands at neuronal nicotinic cholinergic channel receptors, and are effective in controlling synaptic transmission.
以下是翻译结果:
式子为:##STR1## 的新型3-吡啶氧甲基杂环醚化合物,或其药学上可接受的盐或前药,是神经元乙酰胆碱受体选择性和有效的配体,并且在控制突触传递方面具有良好的效果。